Chemomab Therapeutics Ltd. - CMMB Net earnings per one share for the last twelve months

Chemomab Therapeutics Ltd (CMMB) - corporate logo

The historical year-over-year EPS growth (TTM) demonstrates profit dynamics, where the final value of the parameter equals 57.10. The current trend complements the development of unique antibodies to combat tissue fibrosis. The scientific potential of Chemomab Therapeutics (CMMB) is supported by a staff of specialized biologists and an RSU system, although the lack of sales leads to the depletion of reserves to fund clinical trials.

CMMB: Chemomab Therapeutics Ltd. Net earnings per share for the last 12 months 02/11/2024 - 11/18/2026

Chemomab Therapeutics Ltd. - analytical breakdowns and key metrics (CMMB)

- issuer market value details:
Fundamental company valuation:CMMB - Chemomab
Brand item of chemomab.com

Year-over-year (TTM) EPS growth reflects the rate of change in net income per share over a rolling twelve-month period, allowing for an assessment of capital generation efficiency relative to historical performance. By analyzing the YoY TTM earnings per share dynamics, an investor can see the impact of CM-101 clinical successes and FDA orphan designations on the fundamental value of Chemomab Therapeutics (CMMB) and its M&A attractiveness.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Earnings per share for the last twelve months Mereo BioPharma Group (MREO)|Net earnings per share (EPS TTM) protalix.com (PLX)|Net earnings per share (EPS TTM) PLRX (Pliant Therapeutics Inc)|Net earnings per share (EPS TTM) Applied Therapeutics APLT|RNTX - Earnings per share for the last twelve months|Net earnings per share for the trailing year gelteq.com (GELS)|AYTU (aytubio.com) - Net earnings per share for the last 12 months|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)